The health risk information presented here is summarized from Shoreland Travax®, a decision-support tool used by health care providers to perform a detailed health risk analysis based on specific locations, individual travel styles, and traveler risk behaviors. Travax provides practitioners current, independently researched malaria risk and prevention recommendations in a map-based format that goes beyond the annual WHO and US CDC statements included here. Not included here are current reports from Travax of disease outbreaks or environmental events that may pose elevated risks to travelers’ health and safety. The Providers section of this site offers a directory of health care providers who utilize Shoreland Travax for travel health counseling. Learn more about the detailed reports and maps available from these practitioners (includes links to samples).
See also: COVID-19 Traveler Summary
Fully vaccinated: 22.1%
Daily new cases: 0 (7-day rolling average)
Daily new deaths: 0 (7-day rolling average)
Chad is a developing nation classified as low income. Located in central Africa east of Niger and west of Sudan, the climate classifications range from dry (arid) in the north to humid equatorial (long dry season) in the south.
See also: Library article for Yellow Fever
An official yellow fever vaccination certificate may be required depending on your itinerary. Vaccination is usually recommended if you’ll be traveling in areas where there is risk of yellow fever transmission.
- Requirement: A certificate proving yellow fever vaccination is required for travelers aged ≥ 9 months coming from countries with risk of YF transmission. This does not apply to airport transit stops (no exit through immigration checkpoint) in risk countries. Note: Proof of YF vaccination is often required for travelers coming from nonrisk countries, despite Chad's published declaration to the contrary under the International Health Regulations.
- Official Status: listed by WHO as a country where YF transmission risk is present.
Depending on your itinerary, your personal risk factors, and the length of your visit, your health care provider may offer you vaccination against hepatitis A, hepatitis B, influenza, measles, mumps, rubella, meningococcal meningitis, rabies, typhoid fever, or a one time polio booster if you haven't previously received one for travel. Routine immunizations, such as those that prevent tetanus/diphtheria or "childhood" diseases, should be reviewed and updated as needed.
See also: Library article for Malaria
The following is current information as reported by the World Health Organization (WHO) and the US Centers for Disease Control (CDC):
WHO—International Travel and Health (current online update, Country List)(2020) Malaria risk due predominantly to P. falciparum exists throughout the year in the entire country.
- Recommended prevention: C – Risk of P. falciparum malaria, in combination with reported chloroquine and sulfadoxine–pyrimethamine resistance. Mosquito bite prevention plus atovaquone–proguanil or doxycycline or mefloquine chemoprophylaxis (select according to reported side effects and contraindications) a
aAlternatively, for travel to rural areas with low risk of malaria infection, mosquito bite prevention can be combined with stand–by emergency treatment (SBET).
WHO Country List footnote: When available, the date of the most recent update or confirmation is indicated in parentheses in the country list. If no date is indicated, the most recent update or confirmation was provided before 2013.
CDC—Health Information for International Travel (current online edition)Areas with malaria: All.
- Drug resistance3 : Chloroquine.
- Malaria species: P. falciparum 85%, P. malariae, P. ovale, and P. vivax 15% combined.
- Recommended chemoprophylaxis: Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine.4
3 Refers to P. falciparum malaria unless otherwise noted.
4 Primaquine and tafenoquine can cause hemolytic anemia in people with G6PD deficiency. Patients must be screened for G6PD deficiency before starting primaquine or tafenoquine. See Tafenoquine Approved for Malaria Prophylaxis and Treatment for more information.
See also: Library article for Travelers' Diarrhea
High risk exists throughout the country, including in deluxe accommodations. Food and beverage precautions may reduce the likelihood of illness.
Travelers should carry loperamide for self-treatment of diarrhea and, if risk is moderate to high, an antibiotic to add if diarrhea is severe. Consult a knowledgeable health care provider regarding which antibiotic is appropriate for you and most effective for your destination.
Insect- and Arthropod-Borne Diseases
Other Disease and Health Risks
The material below includes information from the US Department of State (DOS), the UK Foreign, Commonwealth & Development Office (FCO), Global Affairs Canada (GAC), and Australia's Department of Foreign Affairs and Trade (DFAT), as well as from additional open-source material. Standard safety precautions that apply to all international travel can be found in the Library article Safety and Security.
Consular Travel Advice
Due to armed conflict and civil unrest, Australia (DFAT) advises avoiding all travel to this country, with the exception of N'Djamena, where DFAT advises reconsidering travel (or avoiding nonessential travel). US (DOS), UK (FCO), and Canada (GAC) have more limited warnings.
High risk of attack by domestic and transnational terrorist groups exists throughout the country, especially in N'Djamena and areas surrounding Lake Chad in Lac and Hadjer-Lamir regions. Targets may include domestic and international organizations and businesses; public places and events, including those frequented by tourists; and transportation systems.
High risk of kidnapping by terrorist groups exists in areas bordering Sudan and Central African Republic and the Sahel semiarid region. Targets may include foreigners (especially Westerners), journalists, nongovernmental organization workers, missionaries, and aid workers.
High risk of violent crime (armed robbery and carjacking) exists throughout the country, including N'Djamena, areas near Lake Chad, and areas outside of Abéché that border Sudan.
Moderate risk of petty crime exists in markets and commercial areas throughout the country.
Scams involving false identity (such as criminals posing as police officers) have been reported.
Protests and demonstrations occur throughout the country and are generally peaceful but have the potential to turn violent without warning. Bystanders are at risk of harm from violence or from the response by authorities. Disruption to transportation, free movement, or the ability to carry out daily activities may occur.
A dangerous security environment exists throughout the country outside of N'Djamena, particularly in areas bordering Sudan and the Central African Republic. Landmines and other unexploded ordnance are present in areas bordering Sudan and Libya.
Significant risk of traffic-related injury or death exists. The road traffic death rate is more than 24 per 100,000 population, the highest risk category. Carefully assess the safety of transportation options before any road travel.
Speed laws are poorly enforced.
Seat belt laws are poorly enforced.
Drunk driving laws are poorly enforced.
Structural standards for vehicles may not meet international standards.
The rainy season is from May through October in southern areas and from June through September in central areas. Floods, mudslides, and landslides may occur.
Selected Embassies or Consulates in Chad
- United States: [+235] 2251-50-17; td.usembassy.gov
- Canada: [+235] 6319-5680; travel.gc.ca/assistance/embassies-consulates/chad
- United Kingdom: U.K. does not have an embassy or consulate in Chad.
- Australia: Australia does not have an embassy or consulate in Chad.
Chad's Embassies or Consulates in Selected Countries
- In the U.S.: chadembassy.us
- In Canada: [+1] 613-680-3322
- In the U.K.: Chad does not have an embassy or consulate in the U.K.
- In Australia: Chad does not have an embassy or consulate in Australia.
HIV testing is not required to obtain a tourist, work, or residence visa.